Customer Logins

Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.

Customer Logins

Healthcare Modeling and Scenario Analysis

Plan with accuracy and efficiency

Do you need to quantify how demographics and disease will impact health care demand?
Do you need to anticipate future demand for specialists at care centers?
Do you need customized market analysis to predict potential for you therapeutic solution?

Based on our unique healthcare microsimulation model, we are able to provide critical support in market planning, scenario analysis and healthcare regulation solutions. We are with you every step of the way to resolve challenges of any scale and any time frame so you can:

  • Estimate future disease prevalence and burden
  • Source essential workforce planning needs
  • Factor anticipated health care costs into strategic plans and hospital operational models
  • Improve sales and revenue forecasting
  • Quantify business impact of healthcare reform
  • Understand the implications of industry and public policy changes


IHS Markit Disease Prevention Microsimulation Model Technical Document

IHS Markit Healthcare Demand Microsimulation Model Technical Document

Service Offerings

Microsimulation Modeling
Our Healthcare Demand Microsimulation Model can be formulated to model disease burden, estimate future chronic diseases, and predict workforce/product/service demand and medical costs
Benefit: Substantiate strategic plans and management strategies in hospitals

Market Planning and Scenario Analysis
Tools to size markets, quantify key drivers, benchmark performance and "wind tunnel" test multiple strategies under alternative outlooks
Benefit: Maximize your return on sales and marketing investments

Regulatory Impact Analysis
Benefit: Quantify the impact of new regulation on product sales, company performance and investment profitability, including acquisitions

Solve Your Business Challenge

Challenge Solution
I need to anticipate future demand for specialists in my care centers. Use microsimulation modeling to pinpoint future needs and requirements for medical staffing.
I need customized market analysis to predict potential for my therapeutic solution. Maximize revenue with a microsimulation model, down to the US county level.


Why Technology is Not a Silver Bullet When It Comes to Diabetes

The evolution of insulin has undergone a tremendous change, from multiple injections routines to continuous subcutaneous insulin infusion through pumps. Pharmaceutical companies have been very active in inventing better methods of drug delivery, reducing the overall dose frequency and launching re-usable delivery systems. Unfortunately, two of the most powerful practices aren’t widely used: making lifestyle changes and adhering to regimens that regulate blood-sugar levels. These behaviors lower health costs and extend quality of life for diabetes patients, but patient buy-in has remained low on both.

Click sections below to explore current trends.


Timothy Dall

​A trained health economist, he brings more than 20 years of experience conducting research and policy analysis in the areas of health economics and outcomes, health workforce, health care delivery and disease cost and prevention. His work applies economic theory, statistical and econometric analysis, cost/benefit analysis, program evaluation, and computer modeling skills. Much of his work uses microsimulation modeling to address complex forecasting and policy issues. Applied research conducted by Mr. Dall supports strategic planning and advocacy work for governments, associations, life sciences companies, payers, provider networks, and non-profit organizations. He has published widely in peer-reviewed journals. Mr. Dall earned his Master of Science in Labor Economics at the University of Wisconsin-Madison, US, and his Bachelor of Science in Economics from Utah State University, Logan, Utah, US.

View Profile

Milena Izmirlieva

Ms. Izmirlieva heads the Life Sciences research team which comprises senior analysts, analysts and health economists covering developed and

View Profile

Gustav Ando

Mr. Ando oversees the development of IHS Markit's global healthcare outlook analysis that focuses on market access, cost of healthcare and n

View Profile

Follow IHS Markit Life Sciences on Twitter



Filter Sort